SCHEMBL7577631

SCHEMBL7577631

O=C(O)C(Nc1ccc(Br)cc1Br)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
POLB P06746 1/20 0.43
ALDH1A1 P00352 8/20 0.43
BCL2L1 Q07817 1/20 0.40
MCL1 Q07820 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
S1PR3 Q99500 1/20 0.40
LMNA P02545 4/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
KDM4E B2RXH2 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585358 0.88 FPR2 (0.49) FPR2L3MBTL1POLBALDH1A1KMT2A
SCHEMBL7574119 0.85 ALDH1A1 (0.56) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL7582089 0.83 FPR2 (0.46) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL18360852 0.80 ALDH1A1 (0.57) FPR2L3MBTL1POLBALDH1A1LMNA
SCHEMBL7583413 0.77 FPR2 (0.67) FPR2ALDH1A1KMT2AMEN1S1PR3
SCHEMBL7576266 0.76 CA1 (0.51) FPR2POLBALDH1A1KMT2AMEN1
SCHEMBL7574039 0.75 FPR2 (0.47) FPR2ALDH1A1LMNACA1CA2
SCHEMBL839473 0.74 MEN1 (0.50) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL11203574 0.74 KMT2A (0.51) FPR2ALDH1A1KMT2AMEN1NPC1
SCHEMBL9298164 0.73 FPR2 (0.47) FPR2ALDH1A1KMT2AMEN1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed